Clinical Trial Update: AZD1152 in Diffuse Large B-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Update on Phase 1/2 clinical trials of AZD1152 (barasertib) in diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• AZD1152 (barasertib)

Snippet

Sponsor: Oxford University Hospitals NHS Trust | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED